A dramatic response to a single dose of infliximab in a patient with prolonged pustular psoriasis derived from inverse psoriasis

被引：5

作者：

Li, Mengmeng ^{[1
]}

Dai, Weiwei ^{[2
]}

Yan, Wei ^{[1
]}

Liu, Yuanzhen ^{[1
]}

Wang, Lian ^{[1
]}

Li, Wei ^{[1
]}

机构：

[1] Sichuan Univ, Dept Dermatovenereol, West China Hosp, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China

[2] Chengdu Univ Tradit Chinese Med Hosp, Dept Dermatovenereol, Chengdu, Sichuan, Peoples R China

来源：

DERMATOLOGIC THERAPY | 2017年 / 30卷 / 04期

关键词：

infliximab; inverse psoriasis; pustular psoriasis; EFFICACY;

D O I：

10.1111/dth.12492

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

We report a case of a 25-year-old Chinese man with an exceptionally prolonged history of pustular psoriasis derived from inverse psoriasis who was unsatisfied with conventional treatment and was successfully treated with a single dose of infliximab without noticeable adverse effects. No recurrence or flaring was observed after 3 months of follow-up. This case illustrates that infliximab may be an effective and safe therapeutic option for patients with refractory pustular psoriasis derived from inverse psoriasis.

引用

页数：3

共 50 条

[21] Resolution of Infliximab-induced Palmar Pustular Psoriasis (PPP) After Switching to Biosimilar Infliximab-DYYB Response
deBruyn, Jennifer
INFLAMMATORY BOWEL DISEASES, 2019, 25 (09) : E104 - E104
[22] Rapid response of spesolimab in biologics - failure patient with generalized pustular psoriasis flare
Jiang, Meng
Li, Yan
Guan, Xin
Li, Linfeng
Xu, Wei
POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (04): : 584 - 586
[23] Paraneoplastic Pemphigus Due to High Malignant non Hodgkin Lymphoma in a Patient with Pustular Psoriasis Treated with Infliximab
Schoeberl, A.
Allmacher, C.
Flegl, N.
Krahl, B.
Krahl, D.
Amon, U.
AKTUELLE DERMATOLOGIE, 2010, 36 (04) : 129 - 132
[24] Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: An analysis of Japanese clinical trials of infliximab
Torii, Hideshi
Sato, Noriko
Yoshinari, Toru
Nakagawa, Hidemi
JOURNAL OF DERMATOLOGY, 2012, 39 (03): : 253 - 259
[25] Infliximab in Combination with Low-Dose Acitretin in Generalized Pustular Psoriasis: A Report of Two Cases and Review of the Literature
Kolt-Kaminska, Marta
Zychowska, Magdalena
Reich, Adam
BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 317 - 327
[26] Successful management of infliximab-induced generalized pustular psoriasis without therapy discontinuation in a patient with psoriatic arthritis
Zheng, Jianfeng
Gao, Yunlu
Ding, Yangfeng
DERMATOLOGIC THERAPY, 2019, 32 (06)
[27] PSORIASIS INDUCED BY INFLIXIMAB IN A PATIENT SUFFERING FROM CROHN'S DISEASE
Manni, E.
Barachini, P.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (03) : 841 - 844
[28] Recalcitrant, generalized pustular psoriasis:: rapid and lasting therapeutic response to antitumour necrosis factor-α antibody (infliximab)
Schmick, K
Grabbe, J
BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (02) : 367 - 367
[29] Hepatotoxicity due to etanercept abated after dose reduction in a patient with pustular psoriasis and without compromised efficacy
Li, Zhengxiao
Xiao, Shengxiang
Ren, Jianwen
Zhang, Yanfei
Tu, Chen
Ji, Fanpu
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2014, 106 (07) : 492 - U1
[30] Non-Hodgkin's T-cell lymphoma in a patient with erythrodermic pustular psoriasis treated with infliximab, cyclosporine, and methotrexate
Tan, E
Grattan, C
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB204 - AB204

← 1 2 3 4 5 →